Rating History for Amylin Pharmaceuticals (AMLN) by BofA Securities

More Stocks Rated by BofA Securities | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/8/2011 N/A Upgrade Neutral
(N/A)		 N/A
(N/A)		 13.71
(30.98)		 125.97% Details